Shandong Pharmaceutical announced that the company's application to issue A-shares to specific targets was accepted by the Shanghai Stock Exchange. The Shanghai Stock Exchange believes that the application documents are complete and in accordance with the legal form, and decided to accept it and review it in accordance with the law. The issue still needs to be reviewed and approved by the Shanghai Stock Exchange, and the registration decision approved by the China Securities Regulatory Commission can only be implemented. There is uncertainty about whether it will eventually pass the review and registration, and the relevant timing.

Shandong Pharmaceutical announced that the company's application to issue A-shares to specific targets was accepted by the Shanghai Stock Exchange. The Shanghai Stock Exchange believes that the application documents are complete and in accordance with the legal form, and decided to accept it and review it in accordance with the law. The issue still needs to be reviewed and approved by the Shanghai Stock Exchange, and the registration decision approved by the China Securities Regulatory Commission can only be implemented. There is uncertainty about whether it will eventually pass the review and registration, and the relevant timing.